消息面上,AI for Science正从概念走向产业化拐点。北美科技大厂集体重押AI制药,模型训练加速、实验需求放大不断向上游传导,创新药产业链正迎来价值重估和增量爆发的双重机遇。据悉,华大智造作为全栈生命科技工具提供商,全读长测序仪业务全球领先,为AI制药提供基础工具测序仪,此前曾与追光生物、新加坡国立大学药学与制药科学系在药物研发及药学研究等方面达成合作。
值得一提的是,近期,华大智造旗下子公司涌生智能与上海人工智能实验室联合发布两项成果——真实实验室场景驱动的自进化多智能体系统 ProtoPilot,以及生命科学领域首个从用户需求到设备可执行的全流程 Agent 评测体系 BioLab Bench,交出了全球生命科学实验室首份 Physical AI 答卷。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.